Researchers have demonstrated that deep learning models can help neurologists interpret epileptic episodes during and between seizures from relatively few scalp electroencephalography (EEG) readings.

Does Big Blue’s toe in the water say more about IBM in particular than it says about healthcare AI in general?

Virtual reality can help quell perceptions of pain as well as dampening the prickling sensations that patients with nerve damage sometimes experience upon being touched.

Researchers have developed an AI-based system that can direct the administering of iron and other red-blood-cell stimulators nearly as well as experienced physicians.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.

The FDA has greenlit an AI algorithm that automatically measures dilation in the heart’s right ventricle on CT images.

A new survey of around 300 youngish parents has found almost two-thirds worried they’re spending so much time distracted by electronic devices that their children’s development may be at risk.

Affronts against privacy and equality—real, perceived or ginned up—may fuel lawsuits by patients whose COVID care incorporated AI.

An MIT spinoff based in Boston and Milan in Italy has earned CE certification for software that flags respiratory infection in wearers of the company’s smartwatch devices.

A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.